# Lung Function in Patients With Early Type 2 Diabetes Mellitus

Study · id `cardio:ct-nct03167918` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03167918](<https://clinicaltrials.gov/study/NCT03167918>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03167918

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

## Technical summary

Registry record NCT03167918. Randomized; double masking; primary purpose treatment. Start 2014-07-21 (actual); primary completion 2017-04-01 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 2/3
- Enrolled: 200 participants (enrolled count; ClinicalTrials.gov record NCT03167918, source copy `cardio:ctgov-nct03167918-2017-05-30`, retrieved 2026-10-26)
- Started: 2014-07-21 (actual) (ClinicalTrials.gov record NCT03167918, source copy `cardio:ctgov-nct03167918-2017-05-30`, retrieved 2026-10-26)
- Primary completion: 2017-04-01 (actual) (ClinicalTrials.gov record NCT03167918, source copy `cardio:ctgov-nct03167918-2017-05-30`, retrieved 2026-10-26)
- Completion: 2017-05-01 (actual) (ClinicalTrials.gov record NCT03167918, source copy `cardio:ctgov-nct03167918-2017-05-30`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03167918-2017-05-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: Lung Function in Patients With Early Type 2 Diabetes Mellitus
- Condition: Type 2 Diabetes Mellitus
- Condition: Pulmonary Function
- Intervention (Drug): Calcium Dobesilate
- Intervention (Drug): Xuefuzhuyu Decoction
- Intervention (Drug): Xuefuzhuyu Decoction & Calcium dobesilate
- Intervention (Drug): metformin
- Intervention (Drug): Mecobalamin Tablets
- Lead sponsor: Liaoning University of Traditional Chinese Medicine
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)

## Provenance

Content hash: e02e07204f99d7fbabbaf582d1bc30eb2721100f39ba8ccc92553281b46a07d2
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
